0001415889-23-008704.txt : 20230524 0001415889-23-008704.hdr.sgml : 20230524 20230524161225 ACCESSION NUMBER: 0001415889-23-008704 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230522 FILED AS OF DATE: 20230524 DATE AS OF CHANGE: 20230524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reeve Emma CENTRAL INDEX KEY: 0001680329 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 23954255 MAIL ADDRESS: STREET 1: C/O PAREXEL INTERNATIONAL CORPORATION STREET 2: 195 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 form4-05242023_080557.xml X0407 4 2023-05-22 0001070081 PTC THERAPEUTICS, INC. PTCT 0001680329 Reeve Emma C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 true false false false 1 Common Stock 2023-05-22 4 M 0 173 33.63 A 7373 D Common Stock 2023-05-22 4 S 0 173 59.5242 D 7200 D Common Stock 2023-05-22 4 M 0 2995 33.02 A 10195 D Common Stock 2023-05-22 4 S 0 2995 59.5335 D 7200 D Common Stock 2023-05-22 4 M 0 3948 33.63 A 11148 D Common Stock 2023-05-22 4 S 0 3948 59.5313 D 7200 D Common Stock 2023-05-23 4 M 0 157 33.63 A 7357 D Common Stock 2023-05-23 4 S 0 157 59.5171 D 7200 D Common Stock 2023-05-23 4 M 0 1093 33.02 A 8293 D Common Stock 2023-05-23 4 S 0 1093 59.5320 D 7200 D Common Stock 2023-05-23 4 M 0 1402 33.63 A 8602 D Common Stock 2023-05-23 4 S 0 1402 59.5378 D 7200 D Stock Option (Right to Buy) 33.63 2023-05-22 4 M 0 173 33.63 D 2028-12-13 Common Stock 173 994 D Stock Option (Right to Buy) 33.02 2023-05-22 4 M 0 2995 33.02 D 2029-01-21 Common Stock 2995 8005 D Stock Option (Right to Buy) 33.63 2023-05-22 4 M 0 3948 33.63 D 2028-12-13 Common Stock 3948 10052 D Stock Option (Right to Buy) 33.63 2023-05-23 4 M 0 157 33.63 D 2028-12-13 Common Stock 157 837 D Stock Option (Right to Buy) 33.02 2023-05-23 4 M 0 1093 33.02 D 2029-01-21 Common Stock 1093 6912 D Stock Option (Right to Buy) 33.63 2023-05-23 4 M 0 1402 33.63 D 2028-12-13 Common Stock 1402 8650 D Stock Option (Right to Buy) 51.16 2030-01-28 Common Stock 10000 10000 D Stock Option (Right to Buy) 66.49 2031-01-05 Common Stock 10000 10000 D Stock Option (Right to Buy) 38.10 2032-01-06 Common Stock 12000 12000 D Stock Option (Right to Buy) 39.42 2033-01-04 Common Stock 10000 10000 D This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.57 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.62 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.71 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Currently exercisable. This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023. /s/ Avraham S. Adler, Attorney-in-Fact 2023-05-24